| 881 |
decreased |
receptor antagonist activity
(GO:0048019)
|
smoothened homolog (human)
(PR:Q99835)
|
None
|
| 713 |
decreased |
abnormal circulating hormone level
(MP:0005418)
|
|
None
|
| 721 |
increased |
|
DNA molecule region
(FMA:84119)
|
None
|
| 560 |
delayed |
estrus
(GO:0060209)
|
|
None
|
| 177 |
functional change |
mitochondrion disassembly
(GO:0061726)
|
mitochondrion
(GO:0005739)
|
None
|
| 579 |
increased |
|
reactive oxygen species
(CHEBI:26523)
|
None
|
| 696 |
decreased |
|
vascular endothelial growth factor A
(PR:000017284)
|
None
|
| 691 |
increased |
acute inflammatory response
(GO:0002526)
|
Cytokine
(FMA:84050)
|
None
|
| 704 |
decreased |
testicular atrophy
(MP:0003205)
|
Testis
(FMA:7210)
|
None
|
| 523 |
decreased |
survival
(MESH:D013534)
|
|
None
|
| 775 |
decreased |
protein secretion
(GO:0009306)
|
|
None
|
| 474 |
decreased |
epithelial cell apoptotic process
(GO:1904019)
|
|
None
|
| 726 |
decreased |
androgen biosynthetic process
(GO:0006702)
|
|
None
|
| 743 |
decreased |
regulation of binding
(GO:0051098)
|
|
None
|
| 744 |
decreased |
protein dephosphorylation
(GO:0006470)
|
|
None
|
| 730 |
decreased |
activin receptor signaling pathway
(GO:0032924)
|
activin receptor complex
(GO:0048179)
|
None
|
| 187 |
increased |
|
fatty liver
(MESH:D005234)
|
None
|
| 767 |
increased |
endocytosis involved in viral entry into host cell
(GO:0075509)
|
|
None
|
| 772 |
occurrence |
epithelial to mesenchymal transition
(GO:0001837)
|
cellular_component
(GO:0005575)
|
None
|
| 769 |
increased |
neuropilin binding
(GO:0038191)
|
|
None
|
| 786 |
decreased |
pattern recognition receptor signaling pathway
(GO:0002221)
|
RNA viral genome
(GO:0019022)
|
None
|
| 790 |
decreased |
translation
(GO:0006412)
|
|
None
|
| 788 |
decreased |
cellular response to type I interferon
(GO:0071357)
|
type I interferon receptor complex
(GO:0038197)
|
None
|
| 429 |
decreased |
|
cholesterol
(CHEBI:16113)
|
None
|
| 1146 |
increased |
Hepatic bridging fibrosis
(HP:0012852)
|
|
2414: COL3A1 Signaling Pathway
|